Dietary Compound Isoliquiritigenin, an Antioxidant from Licorice, Suppresses Triple-Negative Breast Tumor Growth via Apoptotic Death Program Activation in Cell and Xenograft Animal Models

Patients with triple-negative breast cancer have few therapeutic strategy options. In this study, we investigated the effect of isoliquiritigenin (ISL) on the proliferation of triple-negative breast cancer cells. We found that treatment with ISL inhibited triple-negative breast cancer cell line (MDA...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Po-Han, Chiang, Yi-Fen, Shieh, Tzong-Ming, Chen, Hsin-Yuan, Shih, Chun-Kuang, Wang, Tong-Hong, Wang, Kai-Lee, Huang, Tsui-Chin, Hong, Yong-Han, Li, Sing-Chung, Hsia, Shih-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139602/
https://www.ncbi.nlm.nih.gov/pubmed/32164337
http://dx.doi.org/10.3390/antiox9030228

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139602/
https://www.ncbi.nlm.nih.gov/pubmed/32164337
http://dx.doi.org/10.3390/antiox9030228

Ejemplares similares